Bedell Frazier Investment Counselling’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,000
| Closed | -$216K | – | 89 |
|
|
2023
Q2 | $216K | Sell |
4,000
-2,000
| -33% | -$104K | 0.06% | 86 |
|
|
2023
Q1 | $300K | Sell |
6,000
-4,000
| -40% | -$189K | 0.09% | 79 |
|
|
2022
Q4 | $463K | Hold |
10,000
| – | – | 0.12% | 78 |
|
|
2022
Q3 | $387K | Hold |
10,000
| – | – | 0.11% | 75 |
|
|
2022
Q2 | $373K | Hold |
10,000
| – | – | 0.11% | 65 |
|
|
2022
Q1 | $443K | Hold |
10,000
| – | – | 0.11% | 71 |
|
|
2021
Q4 | $425K | Hold |
10,000
| – | – | 0.1% | 77 |
|
|
2021
Q3 | $434K | Hold |
10,000
| – | – | 0.12% | 66 |
|
|
2021
Q2 | $428K | Hold |
10,000
| – | – | 0.11% | 71 |
|
|
2021
Q1 | $387K | Hold |
10,000
| – | – | 0.11% | 69 |
|
|
2020
Q4 | $360K | Hold |
10,000
| – | – | 0.11% | 66 |
|
|
2020
Q3 | $382K | Hold |
10,000
| – | – | 0.14% | 59 |
|
|
2020
Q2 | $351K | Hold |
10,000
| – | – | 0.14% | 53 |
|
|
2020
Q1 | $326K | Hold |
10,000
| – | – | 0.15% | 44 |
|
|
2019
Q4 | $407K | Hold |
10,000
| – | – | 0.16% | 40 |
|
|
2019
Q3 | $407K | Hold |
10,000
| – | – | 0.16% | 42 |
|
|
2019
Q2 | $430K | Sell |
10,000
-4,692
| -32% | -$180K | 0.16% | 41 |
|
|
2019
Q1 | $564K | Hold |
14,692
| – | – | 0.22% | 41 |
|
|
2018
Q4 | $519K | Sell |
14,692
-5,000
| -25% | -$181K | 0.22% | 37 |
|
|
2018
Q3 | $758K | Hold |
19,692
| – | – | 0.21% | 44 |
|
|
2018
Q2 | $644K | Hold |
19,692
| – | – | 0.19% | 42 |
|
|
2018
Q1 | $538K | Hold |
19,692
| – | – | 0.19% | 38 |
|
|
2017
Q4 | $488K | Hold |
19,692
| – | – | 0.18% | 39 |
|
|
2017
Q3 | $574K | Buy |
19,692
+4,692
| +31% | +$130K | 0.26% | 31 |
|
|
2017
Q2 | $416K | Hold |
15,000
| – | – | 0.15% | 39 |
|
|
2017
Q1 | $373K | Hold |
15,000
| – | – | 0.14% | 39 |
|
|
2016
Q4 | $324K | Sell |
15,000
-4,175
| -22% | -$91.1K | 0.13% | 45 |
|
|
2016
Q3 | $456K | Hold |
19,175
| – | – | 0.19% | 40 |
|
|
2016
Q2 | $448K | Sell |
19,175
-4,426
| -19% | -$95.8K | 0.22% | 36 |
|
|
2016
Q1 | $444K | Sell |
23,601
-328,595
| -93% | -$5.77M | 0.23% | 36 |
|
|
2015
Q4 | $6.49M | Buy |
352,196
+8,165
| +2% | +$146K | 3.22% | 12 |
|
|
2015
Q3 | $5.65M | Buy |
344,031
+324,605
| +1,671% | +$5.55M | 3.26% | 10 |
|
|
2015
Q2 | $344K | Hold |
19,426
| – | – | 0.14% | 58 |
|
|
2015
Q1 | $345K | Hold |
19,426
| – | – | 0.14% | 63 |
|
|
2014
Q4 | $257K | Hold |
19,426
| – | – | 0.13% | 51 |
|
|
2014
Q3 | $229K | Hold |
19,426
| – | – | 0.11% | 53 |
|
|
2014
Q2 | $248K | Hold |
19,426
| – | – | 0.13% | 43 |
|
|
2014
Q1 | $263K | Hold |
19,426
| – | – | 0.15% | 46 |
|
|
2013
Q4 | $234K | Buy |
+19,426
| New | +$230K | 0.11% | 57 |
|
|
2013
Q3 | – | Sell |
-19,426
| Closed | -$220K | – | 53 |
|
|
2013
Q2 | $220K | Buy |
+19,426
| New | +$165K | 0.11% | 55 |
|
Other funds holding BSX
Bedell Frazier Investment Counselling's BSX Position: Q3 2023 in Review
Bedell Frazier Investment Counselling sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 4,000 shares — an estimated $216K sold.
Bedell Frazier Investment Counselling first reported a position in BSX in Q2 2013 and held it in 40 quarters. The position peaked at $6.49M in Q4 2015. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.
- Bedell Frazier Investment Counselling reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
- Bedell Frazier Investment Counselling sold 4,000 Boston Scientific shares in Q3 2023, an estimated $216K.
- Bedell Frazier Investment Counselling first reported a position in Boston Scientific in Q2 2013 and held it in 40 quarters.
- Bedell Frazier Investment Counselling's Boston Scientific position peaked at $6.49M in Q4 2015.
- 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.
Based on Bedell Frazier Investment Counselling's 13F filing for Q3 2023, filed 13 Nov 2023.